Vivos Valuation
| RDGL Stock | USD 0.08 0 4.22% |
Vivos seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Vivos Inc from inspecting the company fundamentals such as Current Valuation of 15.27 M, return on equity of -1.17, and Shares Owned By Insiders of 5.41 % as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Vivos' price fluctuation is out of control at this time. Calculation of the real value of Vivos Inc is based on 3 months time horizon. Increasing Vivos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vivos otc stock is determined by what a typical buyer is willing to pay for full or partial control of Vivos Inc. Since Vivos is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vivos OTC Stock. However, Vivos' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0772 | Real 0.0741 | Hype 0.08 | Naive 0.0673 |
The intrinsic value of Vivos' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Vivos' stock price.
Estimating the potential upside or downside of Vivos Inc helps investors to forecast how Vivos otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vivos more accurately as focusing exclusively on Vivos' fundamentals will not take into account other important factors: Vivos Total Value Analysis
Vivos Inc is at this time forecasted to have valuation of 15.27 M with market capitalization of 24.65 M, debt of 295.76 K, and cash on hands of 1.99 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vivos fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.27 M | 24.65 M | 295.76 K | 1.99 M |
Vivos Investor Information
The company recorded a loss per share of 0.01. Vivos Inc last dividend was issued on the 28th of June 2019. The entity had 1:8 split on the 28th of June 2019. Based on the key indicators related to Vivos' liquidity, profitability, solvency, and operating efficiency, Vivos Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Vivos Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vivos has an asset utilization ratio of 0.91 percent. This suggests that the OTC Stock is making $0.009109 for each dollar of assets. An increasing asset utilization means that Vivos Inc is more efficient with each dollar of assets it utilizes for everyday operations.Vivos Ownership Allocation
Vivos Inc shows a total of 359.89 Million outstanding shares. Vivos Inc has 5.41 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vivos Profitability Analysis
The company reported the previous year's revenue of 14.89 K. Net Loss for the year was (2.53 M) with profit before overhead, payroll, taxes, and interest of 2.89 K.About Vivos Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Vivos Inc. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Vivos Inc based exclusively on its fundamental and basic technical indicators. By analyzing Vivos's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Vivos's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vivos. We calculate exposure to Vivos's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vivos's related companies.Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. VIVOS INC operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Vivos' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Vivos' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vivos' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vivos' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vivos' revenue streams: Identify Vivos' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vivos' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vivos' growth potential: Evaluate Vivos' management, business model, and growth potential.
- Determine Vivos' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vivos' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Vivos Growth Indicators
Investing in growth stocks can be very risky. If the company such as Vivos does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 343.5 M | |
| Retained Earnings | -77.1 M |
Other Information on Investing in Vivos OTC Stock
Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.